Novavax Inc(NVAX)
10.32
Change: -0.54 (▼ -5.21%)
As of Tue 12/20/2022 12:31 PM% Of Value
Growth
Value Per Share
:
:
:
-874.94
141.02
-90.5300 (as of 19/12/2022)
Fundamentals Data
| Open | 11.11 | Dividend | 226 |
| Close Price | 10.32 | DivYield | 0 % |
| High | 11.2996 | Growth | 670.6 M |
| Low | 9.871 | Growth% | 141.02 |
| P/e | -1.245 | Volume | 7.3 M |
| P/b | -0.99 | Market Capital | 762.2 M |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 18.96 (as of 20/12/2022) | 50 Days Moving Average Percentage | -67.484098939929 (as of 20/12/2022 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 31.1 M | 34.2 M | 18.6 M | 475.5 M | 1.1 B |
| Cap Spending | -4.1 M | -1.3 M | -1.8 M | -54.6 M | -57.4 M |
| Operating Expenses | 202.8 M | 208.2 M | 139.2 M | 892.3 M | 2.8 B |
| Operating Cash Flow | -171.7 M | -173.9 M | -120.5 M | -416.7 M | -1.6 B |
| Free Cash Flow | -142.8 M | -186.1 M | -138.4 M | -97.1 M | 265.4 M |
| Free Cash Flow Per Share | -9.764 | -10.071 | -5.746 | -1.688 | 3.568 |
| Total liabilities | 317.7 M | 319.1 M | 320.6 M | 467.9 M | 453.9 M |
| Total cash | 135.4 M | 81.9 M | 82.1 M | 648.7 M | 1.5 B |
| ROE% | 2.784 | 1.534 | 0.746 | -1.871 | -3.682 |
| Outstanding Shares | 17.1 M | 22.0 M | 51.5 M | 73.8 M | 76.2 M |
| P/E | -3.909 | -1.245 | -4.081 | -42.432 | -3.663 |
| P/S | 23.044 | 6.706 | 29.02 | 37.316 | 5.573 |
| Revenue USD | 31.1 M | 34.2 M | 18.6 M | 475.5 M | 1.1 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|